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Hydrogels are materials largely used in the formulation of pharmaceuticals since, in
principle, they could produce a release system of zero-order kinetics, which is of great
therapeutic interest.
In this paper, a model was proposed for the description of the main transport phe-
nomena involved in the drug release process from hydrogel matrices (water diffusion,
polymer swelling, drug diffusion and polymer dissolution); the model predictions are
successfully compared with a large set of experimental data, obtained working with ma-
trices systems based on HPMC (Hydroxy Propyl Methyl Cellulose).
The proposed model was found able to reproduce main features of the observed
phenomena, it can thus be adopted for prediction of the performances of drug release
systems from hydrogel matrices.
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Introduction
Solid pharmaceutical systems (matrices) for
oral administration are the most widespread method
to assume drugs, for its compliance and for the
large area available in the intestine to the drug ad-
sorption. Pharmaceutical systems able to release the
dose of drug with a given kinetics are highly de-
sired. In particular, even if not only, the best goal is
the so-called zero-order kinetics for the release of
the drug, i.e. with a constant rate, to equate the drug
consumption rate due to the metabolism. Matrices
made of hydrogels seem to be able to fulfill this re-
quirement, i.e. properly designed matrix (in terms
of composition, as well as dimensions and geome-
try) can give tailored drug release profiles. These
drug delivery systems, once swallowed (during the
in-vitro tests, once immersed in the solvent mimick-
ing the body fluid), start to absorb water from the
surroundings (water up-take). The absorbed water
causes a number of phenomena: hydrogel swelling,
polymer plasticization (lowering of the glass transi-
tion temperature), diffusion coefficient increase,
erosion phenomenon (due to polymer disentangle-
ment). Therefore, the drug can diffuse through
the hydrated hydrogel and then it can be released.
The design of these systems requires a deep knowl-
edge of the phenomena involved during matrix
hydration/dissolution in the stomach and in the gas-
tro-intestinal tract. The phenomena can be de-
scribed in term of mathematical equations (model-
ing) which can be solved by a properly designed
software (numerical code). The mathematical mod-
eling of drug release can indeed significantly facili-
tate the development of new and the optimization
of existing pharmaceutical products. The identifica-
tion and the quantification of the relevant phenom-
ena in the drugs release, by means of properly de-
signed experimental techniques, as well as the
availability of a reliable physical and mathematical
model, are urgent requirements toward effective
formulations of controlled release systems.
The mathematical modeling of the in-vitro drug
release kinetics was the subject of recent reviews1,2.
A detailed overview of the modeling approaches to
describe drug release from matrices systems pro-
posed in literature was given by Siepmann and
Peppas3. In their analysis, the starting point was the
Higuchi treatment4, which was developed to de-
scribe the drug release from an ointment containing
a suspended drug and in contact with a perfect sink.
The Higuchi equation is not directly applicable to
complex systems such as matrices made of poly-
mers and drugs, which could be subject to swelling
and erosion, showing a diffusivity sensible to the
solvent concentration.
Peppas and co-workers developed a compre-
hensive mathematical theory able to describe the
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full set of observed experimental phenomena, dur-
ing the drug release from tablets made of swellable
hydrogels5–8. The full model was named “sequential
layer” since it describes all the phenomena (water
diffusion, swelling, drug diffusion, polymer ero-
sion) layer-by-layer from the external toward the
interior of the tablet. Their model was able to de-
scribe “affine” deformations, i.e. the swelling of cy-
lindrical matrices causes the matrices to increase
their size keeping their shape, and the erosion
causes the matrices to decrease their size, still re-
maining cylinders.
More recently, the finite element methods were
applied to solve the diffusion problem in tablets of
various, even not simple, geometries (convex tab-
lets, hollow cylinders, doughnuts, inwards hemi-
spheres)9, also in presence of moving boundaries10,
or in presence of slowly dissolving drugs11. This
approach was never applied to the description of
swelling and eroding tablets, which is closer to the
real situations.
Grassi and co-workers proposed several ap-
proaches, with increasing complexity, to model the
drug release from solid pharmaceutical forms2. A
simple model based on the drug balance in the dis-
solution medium was developed taking into account
the resistance to the release due to a layer of enteric
coating12. A much more complex model was devel-
oped to describe the release from tablets made of
swellable hydrogels, with spherical drug particles,
poly-dispersed in size and in different physical
states (amorphous, crystalline)13. Even in these
cases, despite the elegance and the completeness of
the analysis proposed, the models were not able to
describe not affine deformations, i.e. the change in
shape of the matrices which was observed experi-
mentally as consequence of the hydration.
Aims of this paper are to describe the steps
which our research group did in the experimental
study and in the modeling of the behavior for con-
trolled drug delivery systems based on hydrogels.
The experimental techniques will be described, and
some of the most relevant results will be reported.
The evolution in the modeling approaches will be
reported, then the final, state-of-the-art model, re-
cently proposed by our research group, will be sum-




The hydrogel used was the Hydroxypropyl
methylcellulose (HPMC, Methocel K15M, a gift
from Colorcon, Varese, Italy). The model drug was
the theophylline (TP, CAS no. 58-55-9, purchased
from Sigma Aldrich, Milan, Italy). Both the materi-
als are powders with mean diameter of the order of
100 m. The materials were used as obtained, ob-
taining cylindrical matrices (tablets) by powder
mixing and compression (see the Methods section).
Distilled water was used as dissolution medium.
Methods
The studies were organized following a
two-steps approach. First, tablets made of pure
polymer were prepared and hydrated, in order to
analyze the swelling, the erosion and the water dif-
fusion phenomena; then, tablets made of polymer
and drug were prepared and hydrated, in order to
analyze also the drug release phenomena.
Pure HPMC studies14,15. Pure HPMC tablets
(0.35 g, 13 mm diameter, 2.3 mm thickness) were
prepared by compressing the polymer powder in a
tabletting machine (Specac PN3000, equipped with
flat-faced punches, diameter 13 mm) by a Carver
Press, using a loading force of 50 kN kept for 5
minutes.
To allow the water uptake only through radial
direction, the tablets were confined between two
glass slides. This system was placed in a thermo-
static bath, in which the dissolution medium was
distilled water, kept at 37 °C and stirred using a
magnetic paddle. All the runs were performed in
triplicate.
At given immersion times, the sample was
withdrawn from the bath and photographed by a
digital camera (HP Photosmart 945) in controlled
light exposure. Light intensity profiles from pic-
tures were evaluated by image analysis. The analy-
ses were performed by considering the picture as a
matrix of pixels with intensity values ranging from
0 (white) to 255 (black). Azimuthal intensity aver-
age was performed to reduce the errors caused, for
instance, by reflections and surface imperfections.
The light intensities were related to the water con-
tent by means of a relationship developed14 and
tuned15 purposely.
After each photograph was taken, the cover
slide was carefully removed, and the swollen tablet
was cut by several thin-walled metallic punch, the
gel layer external to the punch wall was carefully
recovered and quantitatively transferred on a glass
holder. The cutting were repeated by using punches
of decreasing radius, obtaining several annuli and a
central core, which could not be further cut. Each
single annulus, and the central core, were placed on
a different glass holder. All the samples were dried
in an oven at 105°C until they reached a constant
weight. The amount of water in each sample was
thus obtained; at same time, the amount of polymer
in each sample was determined. By this method, the
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water mass fraction and the polymer mass fraction
were obtained as functions of the radial direction.
For different immersion times, the mass fractions
were obtained as function of time. Therefore, the
technique here outlined allows to obtain the evolu-
tions of mass fractions with both the time and the
radial direction. The technique is described with
more details in a previous paper by our research
group15.
Both the techniques, the image analysis and the
gravimetric method, were developed and applied to
the water/polymer measurement, with the aim of
observing and quantifying the hydration and the
erosion phenomena, in matrices systems. The meth-
ods were applied firstly to drug-free systems.
HPMC systems loaded with Theophylline16, 17.
Mixtures of HPMC and TP 50:50 w/w were ob-
tained by powders direct mixing in a mortar. The
cylindrical matrices (0.35 g, 13 mm diameter,
2.0 mm thickness) were prepared by compressing
the powder in a tabletting machine (Specac
PN3000, equipped with flat-faced punches, diame-
ter 13 mm) by a Carver Press, with a loading force
of 50 kN kept for 5 minutes.
In a first set of runs, the matrices were con-
fined between two glass slides, in order to allow the
water uptake only through radial direction18. This
method – named the “radial” experiment – is the
extension to drug loaded matrices of the method de-
scribed in the previous section, which was pointed
out working with pure HPMC matrices15. Each run
were carried out in triplicate. The “sandwich”
(glass-tablet-glass) was immersed in the vessel of
an USP XXVIII type II apparatus (AT7 Smart by
Sotax). The dissolution medium was 0.9 L of dis-
tilled water kept at 37 °C. After selected immersion
times, the sample was withdrawn from the dissolu-
tion vessel, it was photographed by a camera (HP
Photosmart 945) and the cover slide was carefully
removed. Then, the swollen matrix was cut by sev-
eral thin-walled metallic punches with decreasing
diameters. The gel layer external to the i-th punch’s
wall was carefully recovered and quantitatively
transferred on a glass holder. The sample was dried
in an oven at 105°C until it reaches a constant
weight. Finally, each dried sample was fully dis-
solved in 500 mL of distilled water, and the TP con-
tents were assayed spectroscopically by an UV-visi-
ble spectrometer (Lambda 25 by Perkin Elmer), in
quartz cuvettes with optical path length of 10 mm,
at  = 276 nm (the water solutions of TP were
found to follow the Lambert and Beer law, A = aC;
for concentrations up to 20.0 mg/L, the constant
value was found to be a = 0.0764, thus the limit for
absorbance was around 1.5. Of course solutions
which showed absorbance outside of the calibration
range were diluted of a known factor and assayed
once more, accounting for the dilution in the subse-
quent drug mass calculation). At last, the water,
drug and polymer masses were obtained, as func-
tions of time and radial direction.
In a separate set of tests19, the tablets were im-
mersed in an USP dissolution tester type II contain-
ing distilled water kept at 37°C. The tablets were
placed in a suitable sample holder to avoid the
sticking of the matrices on the bottom of the vessel
(a cylinder made of stainless iron wire with a large
mesh size. The cylinder was 5 cm in diameter and
4 cm in height, i.e. it was larger than the tablet,
even after a given time of immersion). In these
tests, the hydration, the erosion, and the drug re-
lease are thus allowed through the full tablet sur-
face. The experiment was thus named the “overall”
experiment. After selected immersion intervals,
hydrated samples were removed, weighted, dried,
weighted once more and at last they were fully dis-
solved, to allow the drug content assaying (each test
was carried out in triplicate). By this way the water
absorbed as well as the polymer and drug residual
into the tablet were determined as function of the
time, allowing to gather the experimental evolu-
tions, for all the masses: drug, polymer and water,
with time. One matrix for each immersion time was
drawn from the bath, cut along one diameter and
photographed. Size (diameter and thickness) and
shape of the hydrated matrices were obtained from
image analysis.
The experiments (both the “radial” and the
“overall” ones) served as the basis to observe and
quantify the drug diffusion and release phenomena,




The hydration and erosion phenomena were
firstly analyzed by a simple model based on the wa-
ter and drug mass balance in the matrices20. The
calculation code was developed by our research
group by solving the balance equations with finite
difference schemes. For simple geometries the PDE
(time and one-direction independent variables)
were solved directly and compared successfully
with known analytical solutions (which are avail-
able for simple cases of non-moving surfaces and
constant diffusivities). The code abilities were im-
proved allowing the solution for moving boundaries
and variable diffusivities. Furthermore, following a
suggestion taken from literature21, the behavior of a
finite cylinder was described in term of the behav-
ior of an infinite cylinder (i.e., with the height very
large with respect to the radius), by means of a
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properly defined correction factor. The code, even
if very simplified, was found able to describe some
real behaviors of controlled drug delivery systems,
both taken from literature and experimentally in-
vestigated by our research group.
The need for the description of more complex
geometries (e.g. convex tablets) calls for a different
approach, since the simple finite difference codes
were not enough to deal with this kind of problems.
Therefore, the use of commercial finite element
based software was required22. Some simple cases
were successfully simulated, taken from literature9,10.
Also, the comparison with the results of the previous
code, based on finite difference, was successfully
carried out. The code was also applied in describing
some data (drug release from bioceramics, ibuprofen
release from MCM-41 matrices) never analyzed be-
fore from the modeling point of view23, and then in
the analysis of data (drug release from bioceramics,
zoledronate release from SBA-15 matrices) produced
in collaboration with other research group24, con-
firming the great interest that the modeling abilities
arouse in the drug release field of study.
Then, a model for the description of all the
phenomena observed (hydration, swelling, water
and drug diffusion, erosion) was proposed and
tuned by comparison with experimental data pro-
duced within our research group19. By this way the
model was proven to be fully descriptive of the
phenomena observed. Therefore, the model was ap-
plied ab-initio to a different set of experimental
data taken from literature25, produced working with
a different system (HPMC of various powder size
loaded with Diclofenac of various powder size, the
tablets were obtained varying the drug-to-polymer
ratio and the compression force) and it was found
able to nicely reproduce the data26. By this way the
model was proven to be fully predictive, since it
was found able to describe the data without the
need for any parameter optimization.
Once the controlled release was described, an-
other big issue for pharmaceutical science arise.
What happens to the drug once administered to liv-
ing beings? Are we able to describe the drug fate
from a modeling point of view? Our research group
dealt with this problem, i.e. the study of the drug
pharmacokinetics. At first27, a compartment model-
ing approach was followed: the human body was
considered as some well mixed vessels (compart-
ments) in which the drug is administered. They (the
compartments) are able to exchange the drug be-
tween them (distribution) and to reproduce the met-
abolic as well as the excretion processes which take
place in the body. The full set of phenomena is in-
deed known as ADME (Administration-Distribu-
tion-Metabolism-Excretion). The proposed model
was successfully applied to some case histories
taken from literature. The compartment approach,
even if very simple and thus potentially useful, suf-
fer of a major drawbacks since it is not very linked
to the real physiology of the living being. There-
fore, the model parameters have to be fitted and
they have no physical meaning. Furthermore, the
description of the body is very far from the reality.
Therefore, a different approach has been followed,
toward the building and the validation of a physio-
logically-based pharmacokinetic model (PBPK). In
this approach, the body was described by several
compartments mimicking some organs, and the
connections between them were designed to repro-
duce real transport phenomena which take place in
the body28. The proposed model was found able to
nicely describe what happens to a drug once admin-
istered for several physiologies (rat, humans) and
for several administration routes (injection, oral ad-
ministration of delayed release drug delivery sys-
tems). The model revealed itself to be a powerful
tool also in the analysis of release data in a particu-
lar case29, when an enteric delayed release tablet for
the administration of Diclofenac was tested both
following the USP protocol (pH = 1 for the first two
hours, and then pH = 6.8 for the following six
hours) and an home-made release test, build to re-
produce the real physiology of the human stomach
(with a slowly decreasing pH in the first two
hours). The expected plasma levels of the drug are
very different if the controlled release system was
tested in the USP apparatus (they stay in the thera-
peutic window for a long time, i.e. the concentra-
tion of the drug is higher than the minimum effec-
tive concentration, M.E.C., and lower than the min-
imum toxic concentration, M.T.C.), or in the appa-
ratus which mimic better the real stomach (the re-
lease is faster, the plasma concentration quickly
overcame the M.E.C. and then decays, exiting from
the therapeutic window). By this study, the rele-
vance of the modeling was confirmed once more:
there was no need for a study involving human be-
ing (which is expensive and which has ethical is-
sues), to predict that the controlled release system
will not perform at its better.
To describe and to discuss the pharmacokinetic
model is beyond the scope of the present work,
therefore it is not reported here. It can be found in
the first paper of the serie28. However, the most in-
teresting application would be the coupling of the
model able to describe the release kinetics from
hydrogel based matrices (the main subject of this
work) with the pharmacokinetic model. A first at-
tempt was done by simulating the drug plasma levels
after the oral administration of a HPMC-TP matrix30.
Once more, the availability of such a tool could
avoid un-necessary testing on living beings, again
proving the importance of mathematical modeling.
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Model equations17,26
The transport of water and drug in the matrix
can be viewed as two pseudo-diffusion phenomena,
which can be described by two transient mass bal-








The balances take into account the masses ac-
cumulation and the transport phenomena which
takes place. In eq. (1), the matrix density is , k
are the water and drug mass fractions, Dk are the
pseudo-diffusion coefficients. The balances have
been written neglecting the convective terms, which
in the un-diluted systems such as the swelling
hydrogels is a strong approximation. However, this
effect is somehow taken into account in the model-
ing of the swelling phenomenon, described below.
The initial conditions for integration are given
by eq. (2), in which 	 is the integration domain
(i.e. the matrix) and k,0 are the initial homo-
geneous mass fraction of water (k = 1) and drug
(k = 2).
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The boundary conditions, given by eq. (3), are
defined on the moving boundary (t).
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In eq. (3), the k,eq are the equilibrium values
for water (k = 1) and drug (k = 2) mass fraction.
The moving boundary, (t), is represented by the
erosion front (the interface between the matrix and
the dissolution medium) both for the water and the
drug.
To solve equations (1), the pseudo-diffusion
coefficients, Dk (for k = 1, 2), have to be evaluated,
accounting for the increase in diffusivity due to the
hydration8:

























*/exp(k) are the values (for k = 1, 2) of the
pseudo-diffusion coefficients in the dry matrix
(1 = 0), and Dk* are the values of the pseudo-dif-
fusion coefficients in the fully swollen matrix
(1 = 1,eq). The density of the partially hydrated
matrix can be calculated by the simplest mixing
















where 1, 2 and 3 are the water, the drug and the
polymer densities, respectively.
The water up-take causes the matrix swelling,
and the polymer disentanglement at the matrix sur-
face causes the matrix erosion. Thus, these two phe-
nomena, swelling and erosion, cause the matrix sur-
face to be a moving boundary. Therefore, there is
the need for modeling the two phenomena, with the
aim of obtaining the evolution of the boundary,
(t). In term of element velocity, v, the governing
equation is:
v v vswe eros  (6)
in which vswe is the size-increase velocity due to the
swelling (a positive value) and veros is the size-de-
crease velocity due to the erosion (a negative
value).














In eq. (7), the j1,diff is the flux of water due to
pure diffusive transport, i.e. due to the concentra-
tion gradient, and the j1,swe is the flux of water
which is required by the swelling phenomenon, i.e.
the water which remains into the gel networks after
the swelling. The basic idea of the modeling is that
the swelling contribution was taken as proportional
to the diffusion contribution, by the model parame-
ter kswe.
It should be noted that the proposed model (eq.
7) actually does not describe the real behavior of
the swelling matrix. Properly, the swelling phenom-
enon takes place in correspondence of the swelling
front (the surface moving inward the matrices in
correspondence of which the polymer undergoes
the transition from dry to hydrated state). The vol-
ume increase due to the hydration causes a network
movement, which propagates toward the erosion
front (the interface between the matrices and the
solvent). By this way, the convective flux omitted
in eq. (1) is somehow taken into account since its
effect is reproduced by the movement of the fully
swollen network (the layers from the swelling front
toward the erosion front).
Furthermore, the boundary movement velocity
due to the erosion phenomenon is accounted for as
a constant velocity, since the erosion is a phenome-
non dictated by chemical and physical features of
the interface between the matrices and the outer
medium, and these features are constant along all
the process:
v keros eros  (8)
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In eq. (8) keros is a constant, and the minus sign
accounts for the inward nature of the erosion. The
equations code were solved using the parameters
value summarized in Table 1.
Results and discussion
The experimental protocols depicted in the Ma-
terials and Methods section gave us access to a very
large set of experimental data. Carrying out a re-
lease test by means of the traditional USP apparatus
II, which consist of a standardized thermostated
vessel equipped with a stirrer blade, will allow
measurements limited to the drug fraction released
for several immersion times. The methods pointed
out in our laboratory, on the other side, make avail-
able data about the matrix size and shape (the ra-
dius in the “radial” test; the radius, the height and
the shape in the “overall” test); and on the compo-
nent’s masses (the drug and the water fraction pro-
file with the radius in the “radial” test; the mass of
each component in the “overall” test). The avail-
ability of these richer sets of data allow to give a
deep insight the phenomena which takes place dur-
ing the drug release process. As an example, the
knowledge of the drug fraction profiles with radius
(in the “radial” test)18 allowed to confirm that the
drug diffusion takes place mainly in the gel layer,
as predicted by equation 48, which was predicted
starting from a model (the free-volume theory), but
it was not confirmed experimentally before.
In Figure 1 all the experimental data gathered
during “radial” tests were summarized, along with
the calculation obtained with the model reported in
section Modeling, and the parameters listed in Ta-
ble 1. The graph above reports the sample radius,
the experimental data being obtained by image
analysis. The graph below reports the masses evo-
lutions, for drug, polymer and water, the experi-
mental data being obtained by the gravimetric/spec-
troscopic method described in section Materials and
Methods. In the same graph, also the photographs
taken for each immersion test are reported. The
model calculations were drawn as lines in the same
figure. The agreement with the data is clearly very
good for each series of data, which means that the
model is able to quantitatively reproduce all the
phenomena which takes place during the drug re-
lease process. In particular, the hydrogel swelling is
correctly described, both in term of swelling radius
(the graph above) and in term of absorbed water
(the graph below, the close squared symbols and the
dotted line). Similarly, the polymer erosion was
correctly predicted (the upward open triangles and
the continuous line in the graph below). Last but
not least, the drug release is correctly predicted (the
closed stars and the dashed line in the graph be-
low). Furthermore, the nature of the drug transport
phenomena (diffusion, limited to the swollen gel
layer) was confirmed by the radial drug fraction
profile (data not reported here, available in the orig-
inal paper18). It is worth noticing that these last data
(the drug release data) would be the only ones ob-
tained by means of the conventional USP test,
whereas the integrated experimental approach de-
picted here allowed a much more informative gath-
ering of data.
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T a b l e 1 – The values of the model parameters used for model simulations
Input parameters
m10 Initial water mass [mg] 7.5 10 Initial water fraction [-] 0.0217
m20 Initial drug mass [mg] 160.35 20 Initial drug fraction [-] 0.4644
m30 Initial polymer mass [mg] 177.42 30 Initial polymer fraction [-] 0.5139
R0 Initial radius [cm] 0.65 1 Water density [mg cm–3] 1000
H Initial thickness [cm] 0.2 2 Drug density [mg cm–3] 1200
V0 Initial volume [cm
3] 0.2654 3 Polymer density [mg cm–3] 1200
1 Diffusive coefficient, 1 [–] 3 2 Diffusive coefficient, 2 [-] 9
1* Equilibrium water fraction [–] 0.97 2* Equilibrium drug fraction[-] 0
Parameters optimized in the simulation of the “radial” test
D1
* Critical water diffusivity [cm2 s–1] 1.6 · 10–6 D2
* Critical drug diffusivity [cm2 s–1] 1.5 · 10–6
kswe Swelling constant [–] 4.35 keros Erosion constant [cm · s
–1] 0.83 · 10–7
Parameters optimized in the simulation of the “overall” test
kswe Swelling constant [–] 5.32 keros Erosion constant [cm · s
–1] 1.97 · 10–7
Figure 2 summarized the experimental data
produced with “overall” tests, and the model calcu-
lations obtained with the model reported in section
Modeling, and the parameters listed in Table 1.
Similarly to Figure 1, here all the data obtained dur-
ing the “overall” tests were reported: in the graph
above, the matrices radius data (open circles) and
the semi-height data (open square) were reported
along with the model calculations (dashed line, ra-
dius; continuous line, semi-height). The experimen-
tal data were obtained by image analysis of photos
of the partially hydrated matrices cut along one di-
ameter. Properly speaking, the swollen tablets are
not cylinders thus it is not correct to talk about ra-
dius and height. The radius is measured in corre-
spondence of the tablet mid-plane and the height is
measured along the tablet axis. The calculated val-
ues were taken accordingly from the code simula-
tions. Once again, the agreement between experi-
mental data and model calculations is very good. In
the graph below, the data reported are the masses of
drug (closed stars), of polymer (upwards open tri-
angles), and water (closed squares) evolutions with
time. The data comes along the model calculations,
in term of drug masses (dashed line), polymer
masses (continuous line), and water masses (dotted
line). The figure reported also the photos of the
samples, hydrated up to a given times, than with-
drawn from the hydration medium and cut along
one diameter. Some of these photos (6, 12, 18 and
24 hours) shown not only the sample, but also the
contour graph obtained by the model, superposed to
the real tablet image. Since the contours superpose
to the images, the code was found able to reproduce
also the shape of the hydrating tablets.
The analysis of Figure 1 and of Figure 2 con-
firmed that the proposed model is able to describe
all the phenomena observed in the experiments.
Simulations of the “radial” and “overall” experi-
ments required the fitting of some parameters (D1
*,
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F i g . 1 – Evolution of cylindrical matrix hydration during the “radial” tests. In the graph above, experimental data (symbols, )
and model calculations (continuous line) for the matrix radius. In the graph below, experimental data (symbols, for the drug,  for
the polymer, for the water masses) and model calculations (dashed line for the drug, continuous line for the polymer, dotted line for
the water masses). The water masses data are to be read on the right axes. Photos of the samples just after the removal from the
hydration bath are also reported.
D2
*, kswe and keros for the “radial” test; kswe and keros
for the “overall” test). Therefore, the model cannot
be defined a predictive tool in this case. However,
the proposed model has predictive abilities, since it
was used to describe the release of a different drug
(Diclofenac), using a different hydrogel (HPMC of
different powder size), from tablets obtained under
different preparative conditions (drug-to-polymer
ratio, compaction force)25, and it was able to predict
the drug release kinetics without asking for a fur-
ther parameter optimization26.
The solution of the balance equations in pres-
ence of the moving boundaries requires a careful re-
definition of the volume elements meshing during
the process. Figure 3 shown the deformed meshes
for some of the immersion times investigated (6,
12, 18 and 24 hours). The increase in size due to the
swelling phenomenon, which for the investigated
times overcomes the reduction in size expected be-
cause the erosion phenomenon, is evident from the
graph, and it causes a deformation of the mesh
shape and position, as well as the shape change,
compared with the initial shape (the black rectan-
gle). The Figure 3 reports also lines which identify
the layer of identical water concentration.
As described below eq. 7, due to mathematical
difficulties in implementation, the code does not lo-
calize the swelling phenomenon were it really takes
place (somewhere inside the matrix). The code in-
stead was built in an alternative way, imposing the
movement to the erosion front, whereas the remain-
ing of the integration volume was allowed to un-
dergo free displacements, to follow the surface
movement, while the elements on the radial axis
cannot move in the radial direction and the ele-
ments on the symmetry plane cannot move in axial
direction. This mathematical shortcut, however, in
principle is able to capture the features of the swell-
ing matrices, and, accurately tuned, the resulting
code was found able to reproduce the real observed
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F i g . 2 – Evolution of cylindrical matrix hydration during the “radial” tests. In the graph above, experimental data (symbols, 
for the radius and  for the semi-height) and model calculations (dashed line for the radius and continuous line for the semi-height).
In the graph below, experimental data (symbols,  for the drug,  for the polymer,  for the water masses) and model calculations
(dashed line for the drug, continuous line for the polymer, dotted line for the water masses). The water masses data are to be read on
the right axes. Photos of the samples just after the removal from the hydration bath and sample cutting are also reported.
behavior. The displacement of the full integration
domain is shown in Figure 3, which describes what
happens to the mesh after several times of
hydration. The boundary as well as the deformed
mesh elements are reported. The propagation of the
surface velocity on the mesh is clearly evident. The
surface velocity is actually due to both the swelling
and the erosion phenomena, because of equation 6,
the reasoning reported above applying to the total
velocity.
Conclusions
In this work, the problem of controlled drug re-
lease from hydrogel based matrices was described
in detail.
Some experimental techniques, pointed out in
the past by our research group, were described and
some interesting results were reported. The drug
content in the matrices, as function of time and radial
direction, were measured by means of a protocol
based on gravimetric and spectroscopic measure-
ments, providing a powerful piece of information, to
our knowledge never reported before in literature.
Several modeling approaches, experienced by
our research group, were summarized and the last
model obtained was reported, along with some of its
performances. The model was proven to be descrip-
tive and, in some cases, predictive of what happens
to a hydrogel based matrix once swallowed.
The importance of the modeling in the studies
related to the controlled release of drug was thus
emphasized, also mentioning the needs for the com-
pletion of the general framework by means of a re-
liable pharmacokinetic model.
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F i g . 3 – The deformation of the mesh due to the hydration, for some of the investigated immersions times (6, 12, 18 and 24
hours). The contour lines identify the concentration of water profiles. The black rectangle identifies the initial matrix
shape (initial radius and initial semi-height).
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